改善血小板输注实践的机会:覆盖22家医院的大型回顾性审计
该多中心回顾性分析纳入2017年1月1日至2022年6月30日收治的成人患者,分析821950例入院中的56825次血小板输注事件,发现23.2%不符合指南。抗血小板治疗、心脏手术、侵入性操作、免疫介导性血小板减少症和初级预防中不合规率较高。学术医院不合规风险低于社区医院(OR 0.768,95%CI 0.678-0.871,p<0.001)。
要点
- 抗血小板治疗(48.5%)、心脏手术(49.7%)、初级预防(47.2%)不合规率较高。
- 学术医院不合规风险低于社区医院(OR 0.768,95%CI 0.678-0.871)。
核心结论
- 尽管有循证指南,不必要的血小板输注仍持续存在,需要针对性干预以优化输注实践。
研究设计与样本
- 多中心回顾性分析,纳入2017年1月1日至2022年6月30日收治于综合内科、亚专科内科和重症监护的成人患者,覆盖22家医院,分析821950例入院和56825次血小板输注事件。
主要发现
- 抗血小板治疗背景下不合规1515次(48.5%),心脏手术1935次(49.7%),侵入性操作4648次(29.2%),免疫介导性血小板减少症596次(32.9%),初级预防7370次(47.2%)。
- 调整医生特征后,学术医院指南不合规血小板输注风险低于社区医院(OR 0.768,95%CI 0.678-0.871,p<0.001)。
- 医生专科影响指南依从性,但医生性别或执业年限不影响。
关键数值与推荐
- 指南依从定义为:神经外科、心脏手术或体外膜氧合指征时血小板低于100×10^9/L;侵入性操作、出血或治疗性抗凝时低于50×10^9/L;无免疫介导性血小板减少症时低于10×10^9/L。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite evidence-based guidelines to inform platelet transfusion practice, unnecessary platelet transfusion persists. We performed a multicentre retrospective analysis of adults admitted to general medicine, subspecialty medicine and critical care from 1 January 2017 to 30 June 2022. Platelet transfusion guideline compliance was defined as platelet transfusion below 100 × 109/L for neurosurgical, cardiac surgery or extracorporeal membrane oxygenation indications, below 50 × 109/L for invasive procedures, bleeding or therapeutic anticoagulation, and below 10 × 109/L if the patient did not have an immune-mediated thrombocytopenia. We analysed 821 950 patient admissions at 22 hospital sites, identifying 56 825 platelet transfusion events. Overall, 13 199 (23.2%) platelet transfusion events were guideline-non-compliant. High rates of non-compliant transfusions were observed in the context of anti-platelet therapy (n = 1515, 48.5% non-compliant), cardiac surgery (n = 1935, 49.7%), invasive procedures (n = 4648, 29.2%), immune-mediated thrombocytopenia (n = 596, 32.9%) and primary prophylaxis (n = 7370, 47.2%). After adjusting for physician characteristics, there was a lower risk of guideline-non-compliant platelet transfusions at academic than at community hospitals (odds ratio [OR] 0.768, 95% confidence interval [CI] 0.678-0.871, p < 0.001). Physician specialty, but not physician gender or years in practice, influenced guideline compliance. These findings underscore the need for targeted intervention to optimize platelet transfusion practices, minimize avoidable transfusion reactions, reduce costs and mitigate platelet shortages.
引用
- Ryan S, Liu Y, Raza S, et al. Opportunities for improving platelet transfusion practice: A large retrospective audit across 22 hospitals. Br J Haematol. 2025. PMID: 41449709. doi:10.1111/bjh.70304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。